Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer

Name: Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
License: Public Domain

Zhejiang Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

stage iv esophagus squamous cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 146460
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.